PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pharmacy, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Department of Pharmaceutics, Faculty of pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.\', \'Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.\', \'School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.\', \'Polish Mother\'s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. sahebkara@mums.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/978-3-030-64872-5_11
?:hasPublicationType
?:journal
  • Advances in experimental medicine and biology
is ?:pmid of
?:pmid
?:pmid
  • 33861442
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.867
?:rankingScore_hIndex
  • 104
?:title
  • Possible Mechanisms and Special Clinical Considerations of Curcumin Supplementation in Patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33861442>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33861442>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all